Fortis Technologies

What Fortis Technologies does

Fortis Technologies Ltd is a privately held UK manufacturer of HPLC and UHPLC chromatography columns, founded in 2005 and headquartered in Neston, Cheshire. The company designs, develops, and produces a full range of reversed-phase and normal-phase stationary phases packed into analytical, capillary, and preparative column formats, with two core proprietary technologies: Evosphere monodisperse fully porous particles (MFPP), launched in 2023 as its next-generation platform, and SpeedCore core-shell technology. The product portfolio spans the flagship Evosphere and SpeedCore lines, FortisBIO sub-brands for peptide/protein analysis, classical Fortis phase chemistries (C18, C8, Diphenyl, HILIC, Cyano, Amino), UniverSil variants, capillary columns, and supporting accessories such as guard columns, filters, and bio-inert INERT hardware.

Fortis serves laboratories across four primary verticals: pharmaceutical drug development and quality control, environmental testing (notably PFAS analysis), food and beverage safety testing (mycotoxins), and bioanalytical/omics research (metabolomics, lipidomics, oligonucleotides). The company has built an extensive application database of validated methods and integration partnerships, including ChromSword automated method development software and capillary fitting compatibility with Thermo, SCIEX, and Bruker LC-MS instrumentation.

The business model is B2B sales of physical column products and consumables through a hybrid channel of international distributors and direct sales inquiries, supplemented by content marketing, technical application notes, conference presence at events such as ISC, HPLC Symposium, Pittcon, and Analytica, and a LinkedIn/newsletter funnel. Pricing is not publicly disclosed; the company offers promotional method development kits and emphasizes technical support and method development assistance as part of its value proposition. Fortis operates as an independent, bootstrapped, founder-led company with no disclosed external funding, acquisitions, or institutional investors.

Name

Fortis Technologies

Legal name

Fortis Technologies Ltd

Website

https://fortis-technologies.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Fortis Technologies is a UK-based manufacturer of HPLC and UHPLC chromatography columns, founded in 2005. It sells Evosphere monodisperse and SpeedCore core-shell columns, plus FortisBIO bioanalytical products, to pharmaceutical, environmental, food safety, and omics laboratories via international distributors.

Ownership category

akta.pro rank

Product category

Chromatography columns

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

Laboratory Analytical Instruments (3826)

akta.pro primary industry

Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)

akta.pro secondary industries

Downstream Processing & Purification Technologies (chromatography, filtration, centrifugation) (HLAAAJAB), Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI)

Keywords

• HPLC columns
• UHPLC columns
• Chromatography stationary phases
• Core-shell particles
• Monodisperse particles

Headquarters

HQ city

Neston

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. HPLC/UHPLC Column Sales: Manufacture and supply of HPLC and UHPLC columns for chromatography applications. Products include analytical columns, capillary columns, and preparative sizes packed with various RP and NP stationary phases. Revenue generated through direct product sales and distributor network.
2. Accessories and Consumables: Guard columns, filters, and other chromatography accessories. Recurring revenue from consumable products that protect and extend analytical columns.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Fortis Technologies manufactures and supplies a full range of reversed-phase (RP) and normal-phase (NP) HPLC and UHPLC chromatography stationary phases packed in analytical, capillary and preparative column formats. Core offerings are built on proprietary particle platforms — Evosphere Monodisperse Fully Porous Particles (MFPP) for high efficiency and resolution, and SpeedCore core-shell particles for UHPLC speed and throughput — plus INERT bio-inert coated hardware for biomolecule separations and an extensive line of Fortis, FortisBIO and UniverSil phase chemistries (C18, C8, Diphenyl, H2o, HILIC, Cyano, Amino and others). Supporting offerings include guard columns, filters, prep columns and capillary columns for high-sensitivity applications.

Product overview

Fortis Technologies is an HPLC Column company founded on Research, Development and Manufacture of HPLC and UHPLC columns. The company manufactures and supplies a full range of RP (Reversed Phase) and NP (Normal Phase) stationary phases packed in analytical, capillary and preparative sizes. The core product portfolio includes: Evosphere (monodisperse fully porous particles - the latest generation technology for enhanced efficiency and resolution), SpeedCore (core-shell technology for HPLC and UHPLC with eight phase chemistries), and the Fortis branded columns (C18, Diphenyl, H2o, C8, HILIC, Cyano, Amino variants). Sub-brands include FortisBIO for bioanalytical applications and UniverSil variants for standard applications. The company also offers UHPLC columns using 1.7µm particles, INERT hardware with bio-inert coating for sensitive applications, guard columns, filters, and capillary columns for specialized high-sensitivity analysis.

Differentiator

Problem solved

Functional benefit

Products and services

• Evosphere Monodisperse Fully Porous Particle (MFPP) HPLC and UHPLC columns providing next-generation efficiency, selectivity and scalability for analytical and bioanalytical separations; available in multiple phase chemistries including C18, C18/AR, C18/PFP, Diphenyl, AQUA, PFP, Phenyl-Hexyl, RP18-Amide and C12.
• SpeedCore Core-shell HPLC and UHPLC columns designed to offer enhanced efficiency, speed and resolution of analysis, available in eight phase chemistries providing hydrophobic, dipole and hydrophilic interactions for orthogonal selectivity.
• SpeedCore BIO Core-shell particle columns designed for biomolecule analysis including peptide and protein separations.
• FortisBIO Bioanalytical HPLC columns for peptide and protein analysis, including C18, C4, C8 and Phenyl variants for biomolecule separations.
• Fortis C18 Octadecyl silane (C18) reversed phase HPLC column for general analytical separations.
• Fortis Diphenyl Phenyl stationary phase HPLC column providing unique selectivity for metabolites and aromatic compounds.
• Fortis H2o Polar endcapped C18 HPLC column optimized for analysis of polar compounds and water-soluble analytes.
• Fortis C8 Octyl silane (C8) reversed phase HPLC column for less hydrophobic separations than C18.
• Fortis HILIC Hydrophilic Interaction Liquid Chromatography (HILIC) column for separation of highly polar molecules.
• Fortis HILIC DIOL Diol phase HILIC column for polar compound separations.
• Fortis Cyano Cyano (nitrile) stationary phase HPLC column for intermediate polarity separations.
• Fortis Amino Aminopropyl stationary phase HPLC column for carbohydrate and amino acid analysis.
• UniverSil C18 HPLC column product line for standard reversed phase applications.
• UniverSil HS High sensitivity C18 column variant for enhanced sensitivity applications.
• UniverSil BIO Bioanalytical C18 column variant for biomolecule applications.
• Fortis Pace HTS High throughput screening HPLC column for rapid analytical separations.
• Capillary Columns Capillary format HPLC columns using monodisperse fully porous particles for increased sensitivity with low-abundance or high-value molecules in applications including metabolomics and biopharmaceutical peptide/protein analysis, with capillary fitting guides for Thermo, SCIEX and Bruker LC-MS systems.
• Prep Columns Preparative scale HPLC columns for purification and scale-up applications across the Fortis phase chemistry range.
• Guards and Filters Guard columns and column filters designed to protect analytical columns from contamination and extend column lifetime.
• INERT Hardware Bio-inert coated column hardware passivated to prevent unwanted interactions with chelators, peptides and other challenging compounds; available packed with multiple Evosphere stationary phases for biomolecule analysis including oligonucleotides, peptides and proteins.
• ChromSword Method Development Integration Validated integration of 8 Evosphere chemistries within ChromSword automated HPLC method development software, letting customers simplify method development and leverage orthogonal selectivity in an automated workflow.

Quantifiable outcome

• Improved sensitivity for low abundance molecules using capillary columns combined with monodisperse particles
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Partnerships

One partnership is on record.

• International DistributorscoreChannel Partner/ Reseller/ DistributorNetwork of international distributors selling Fortis HPLC/UHPLC columns in various geographic regions. The company is actively expanding its distributor network and offers inquiries about becoming a distributor through the contact page.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Hichrom Limited: UK-based specialist HPLC column manufacturer (ACE, ACE Excel, Aromatic, Mixed-Mode). Comparable as a similarly sized independent UK specialty column vendor with overlapping chemistries and a parallel focus on method-development support.
• Supelco (MilliporeSigma / Merck): Specialty column brand within Merck/MilliporeSigma (Ascentis, Discovery, Titan) offering HPLC and UHPLC columns with parallel applications across pharma, food, and environmental testing. Direct alternative for chromatographers evaluating Fortis columns.
• Restek Corporation: Privately held US manufacturer of HPLC and UHPLC columns (Raptor, Force, Roc) plus accessories. Closely comparable as a specialty consumables-focused chromatography vendor serving pharma, environmental, and food safety end markets.
• Phenomenex: Direct competitor manufacturing HPLC/UHPLC columns (Luna, Kinetex, Synergi). Operates in the same product category with overlapping chemistries (core-shell, monodisperse) and serves the same pharmaceutical, environmental, and food safety labs as Fortis.
• YMC Co., Ltd. Japanese specialty column manufacturer (YMC-Triart, YMC-Pack, Meteoric, BioPro IEX). Highly comparable niche/specialty HPLC and bio-purification column vendor serving pharmaceutical and biopharma customers globally.
• Macherey-Nagel: German manufacturer of HPLC columns (Nucleodur, Nucleoshell, Chromabond) plus core-shell and HILIC chemistries. Closely comparable specialty column vendor targeting pharmaceutical, environmental, and food analytics with direct overlap to Fortis's Evosphere and SpeedCore lines.

Broad incumbents

• Waters Corporation: Major instrument manufacturer (ACQUITY UPLC, Alliance) that also sells proprietary column lines (BEH, CSH, HSS, MAX). Competes head-on with Fortis in UHPLC columns while controlling a much larger installed base of instruments that anchor method-of-record decisions.
• Thermo Fisher Scientific: Diversified scientific instrument and consumables giant whose Hypersil GOLD, Accucore, and Acclaim column lines compete with Fortis, while broader LC-MS, ion chromatography, and chromatography software businesses create a wide incumbency advantage.
• Shimadzu Scientific Instruments: Major LC instrument vendor (Nexera, i-Series) with proprietary column lines (Shim-pack, Shim-pack Scepter) servicing pharmaceutical and environmental laboratories. Competes with Fortis through both instruments and captive columns.
• Agilent Technologies: Broad analytical instrument leader (InfinityLab LC, GC, MS) with its own column portfolio (ZORBAX, Poroshell, AdvanceBio). Directly comparable column chemistries plus the captive instrument installed base that drives recurring column demand.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fortis-technologies

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fortis Technologies